XORTX Therapeutics Statistics

Total Valuation

XRTX has a market cap or net worth of $5.05 million. The enterprise value is $1.23 million.

Market Cap	5.05M
Enterprise Value	1.23M

Important Dates

The next estimated earnings date is Tuesday, August 13, 2024, before market open.

Earnings Date	Aug 13, 2024
Ex-Dividend Date	n/a

Share Statistics

XRTX has 2.90 million shares outstanding. The number of shares has increased by 25.91% in one year.

Shares Outstanding	2.90M
Shares Change (YoY)	+25.91%
Shares Change (QoQ)	+21.52%
Owned by Insiders (%)	3.35%
Owned by Institutions (%)	6.42%
Float	2.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	0.96
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.03
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.68, with a Debt / Equity ratio of 0.01.

Current Ratio	13.68
Quick Ratio	11.34
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	14.19

Financial Efficiency

Return on equity (ROE) is -64.90% and return on invested capital (ROIC) is -208.66%.

Return on Equity (ROE)	-64.90%
Return on Assets (ROA)	-51.50%
Return on Capital (ROIC)	-208.66%
Revenue Per Employee	n/a
Profits Per Employee	-$1.11M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.84% in the last 52 weeks. The beta is -0.09, so XRTX's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	-69.84%
50-Day Moving Average	2.20
200-Day Moving Average	2.78
Relative Strength Index (RSI)	39.33
Average Volume (20 Days)	171,219

Short Selling Information

The latest short interest is 2,175, so 0.07% of the outstanding shares have been sold short.

Short Interest	2,175
Short Previous Month	1,735
Short % of Shares Out	0.07%
Short % of Float	0.08%
Short Ratio (days to cover)	0.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-5.23M
Pretax Income	-3.34M
Net Income	-3.34M
EBITDA	-3.49M
EBIT	-3.60M
Earnings Per Share (EPS)	-$1.36

Full Income Statement

Balance Sheet

The company has $3.84 million in cash and $14,037 in debt, giving a net cash position of $3.82 million or $1.32 per share.

Cash & Cash Equivalents	3.84M
Total Debt	14,037
Net Cash	3.82M
Net Cash Per Share	$1.32
Equity (Book Value)	2.49M
Book Value Per Share	0.86
Working Capital	4.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.40 million and capital expenditures -$1,638, giving a free cash flow of -$5.40 million.

Operating Cash Flow	-5.40M
Capital Expenditures	-1,638
Free Cash Flow	-5.40M
FCF Per Share	-$2.23

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.91%
Shareholder Yield	-25.91%
Earnings Yield	-66.21%
FCF Yield	-106.98%

Analyst Forecast

The average price target for XRTX is $14.00, which is 704.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	704.60%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:9.

Last Split Date	Nov 14, 2023
Split Type	Reverse
Split Ratio	1:9

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a